Kelly R. Thornburg
Corporate Officer/Principal at CHIMERIC THERAPEUTICS LIMITED
Kelly R. Thornburg active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Corporate Officer/Principal | 02/02/2022 | - |
Career history of Kelly R. Thornburg
Former positions of Kelly R. Thornburg
| Companies | Position | Start | End |
|---|---|---|---|
| XBIOTECH INC. | Chief Operating Officer | 07/06/2015 | 04/05/2017 |
| KITE PHARMA INC | Corporate Officer/Principal | - | - |
| AMGEN INC. | Corporate Officer/Principal | - | - |
Training of Kelly R. Thornburg
| Rockhurst University | Undergraduate Degree |
Statistics
International
| United States | 5 |
| Australia | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| XBIOTECH INC. | Health Technology |
| AMGEN INC. | Health Technology |
| CHIMERIC THERAPEUTICS LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Stock Market
- Insiders
- Kelly R. Thornburg
- Experience
